Accumulating evidence suggests that the role of TNF-α and IL-17 in IBD pathogenesis is more complicated than previously thought since these cytokines can exert both pro- and anti-inflammatory effects [78,79]. The gene discussed is IL17A; the disease is inflammatory bowel disease.